Transcatheter aortic valve replacement in low-risk patients: 2-year results from the LRT trial
Abstract
Previous studies from the Low Risk TAVR (LRT) trial demonstrated that transcatheter aortic valve replacement (TAVR) is safe and feasible in low-risk patients, with excellent 30-day and 1-year outcomes. The objective of this study was to report clinical outcomes and the impact of 30-day hypoattenuated leaflet thickening (HALT) on structural valve deterioration (SVD) 2 years after TAVR. The LRT trial was the first Food and Drug...
Paper Details
Title
Transcatheter aortic valve replacement in low-risk patients: 2-year results from the LRT trial
Published Date
Jul 1, 2021
Journal
Volume
237
Pages
25 - 33
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History